Cargando…
Authors’ Reply to Vrachatis et al. “Pharmaco-Immunomodulatory Therapy in COVID-19”
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471515/ https://www.ncbi.nlm.nih.gov/pubmed/32880806 http://dx.doi.org/10.1007/s40265-020-01396-8 |
| _version_ | 1783578783908888576 |
|---|---|
| author | Rizk, John G. Kalantar-Zadeh, Kamyar Mehra, Mandeep R. Lavie, Carl J. Rizk, Youssef Forthal, Donald N. |
| author_facet | Rizk, John G. Kalantar-Zadeh, Kamyar Mehra, Mandeep R. Lavie, Carl J. Rizk, Youssef Forthal, Donald N. |
| author_sort | Rizk, John G. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7471515 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Springer International Publishing |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-74715152020-09-04 Authors’ Reply to Vrachatis et al. “Pharmaco-Immunomodulatory Therapy in COVID-19” Rizk, John G. Kalantar-Zadeh, Kamyar Mehra, Mandeep R. Lavie, Carl J. Rizk, Youssef Forthal, Donald N. Drugs Letter to the Editor Springer International Publishing 2020-09-03 2020 /pmc/articles/PMC7471515/ /pubmed/32880806 http://dx.doi.org/10.1007/s40265-020-01396-8 Text en © Springer Nature Switzerland AG 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Letter to the Editor Rizk, John G. Kalantar-Zadeh, Kamyar Mehra, Mandeep R. Lavie, Carl J. Rizk, Youssef Forthal, Donald N. Authors’ Reply to Vrachatis et al. “Pharmaco-Immunomodulatory Therapy in COVID-19” |
| title | Authors’ Reply to Vrachatis et al. “Pharmaco-Immunomodulatory Therapy in COVID-19” |
| title_full | Authors’ Reply to Vrachatis et al. “Pharmaco-Immunomodulatory Therapy in COVID-19” |
| title_fullStr | Authors’ Reply to Vrachatis et al. “Pharmaco-Immunomodulatory Therapy in COVID-19” |
| title_full_unstemmed | Authors’ Reply to Vrachatis et al. “Pharmaco-Immunomodulatory Therapy in COVID-19” |
| title_short | Authors’ Reply to Vrachatis et al. “Pharmaco-Immunomodulatory Therapy in COVID-19” |
| title_sort | authors’ reply to vrachatis et al. “pharmaco-immunomodulatory therapy in covid-19” |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7471515/ https://www.ncbi.nlm.nih.gov/pubmed/32880806 http://dx.doi.org/10.1007/s40265-020-01396-8 |
| work_keys_str_mv | AT rizkjohng authorsreplytovrachatisetalpharmacoimmunomodulatorytherapyincovid19 AT kalantarzadehkamyar authorsreplytovrachatisetalpharmacoimmunomodulatorytherapyincovid19 AT mehramandeepr authorsreplytovrachatisetalpharmacoimmunomodulatorytherapyincovid19 AT laviecarlj authorsreplytovrachatisetalpharmacoimmunomodulatorytherapyincovid19 AT rizkyoussef authorsreplytovrachatisetalpharmacoimmunomodulatorytherapyincovid19 AT forthaldonaldn authorsreplytovrachatisetalpharmacoimmunomodulatorytherapyincovid19 |